← Back to Clinical Trials
RecruitingNCT06548061

D20054;LITT for Spine Tumors

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

ConditionSpinal Metastases
SponsorDartmouth-Hitchcock Medical Center
Study TypeINTERVENTIONAL
PhaseN/A
Enrollment25
SexALL
Min Age18 Years
Max AgeN/A
Start Date2024-05-16
Completion2029-06-01
Interventions
ClearPoint Prism

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The objective of this clinical study is to evaluate the efficacy and safety of spinal laser interstitial therapy in the treatment of metastatic spinal tumors. The investigators hypothesize that rates of local tumor control are comparable between conventional open surgical techniques and spinal laser interstitial therapy.

Eligibility Criteria

Inclusion Criteria: 1. Histology confirmed spinal tumor involving the T2-T12 spine segments. 2. Indication for spine stereotactic radiosurgery or palliative intervention. 3. Normal neurologic exam at the time of presentation (Frankel grade E). Exclusion Criteria: 1. Contraindication to MRI 2. ANY neurologic deficit 3. Tumor spanning more than 3 consecutive vertebral segments 4. Contraindication to general anesthesia 5. Pregnancy

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology